Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
Quick links
HomeAbout MerckProductsNewsroomInvestor InformationCareersResearchLicensingThe Merck Manuals
Patients & Caregivers
Medical resources to keep you educated and informed
Healthcare Professionals
Your Direct Line to Merck Resources
Products
Our medicines and vaccines
Merck Authorized Distributors
Worldwide
Locations
Merck Pipeline

Privacy Policy
A summary of the company's research pipeline - Opens new window
Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. The interactive content on Merck.com requires the Adobe Flash Player, which you can download for free here.
The Merck Manuals A trusted source for medical information available free online.

News
NYSE | MRK 40.000000 | -0.000000 4:02 PM ET | 16 May 2008
Product News
Read the latest news on Merck medicines and vaccines
Research & Development News
Read the latest news on Merck Research and Development
Corporate News
Merck Wins Appeal in VIOXX® Case
Financial News
Merck Reports First-Quarter 2008 Financial Results

Focus On
Public Policy
Merck's position on key public policy issues
SINGULAIR® (montelukast)
Statement: FDA early communication on safety review of SINGULAIR
MerckVaccines.com
Direct ordering, account management, and product information
FOSAMAX® (alendronate sodium)
Statement regarding Osteonecrosis of the Jaw
VIOXX Information Center
Information on the voluntary withdrawal of VIOXX® (rofecoxib)
This U.S. Web site is subject to Merck.com Terms of Use RSS RSS    PODCAST Podcast
Contact Merck Site Map Privacy Policy Opens new window Terms of Use Copyright 1995-2008 Merck & Co., Inc.